OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

Charity number: 1178552

CDS UK (Clinic for Dissociative Studies) Annual Report and Financial Statements

Page
Reference and administrative details of the charity 1
Trustees' report 2
Independent auditor’s report 10
Statement of financial activities 13
Statement of financial position 14
Statement of cash flows 15
Notes to the financial statements 16

CDS UK (Clinic for Dissociative Studies) REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY FOR THE PERIOD FROM 1st April 2024 to 31st MARCH 2025

Trustees

Prof N MacLennan (Chair) Appointed 4 July 2022 (as a Trustee); 14 November 2022 (As Chair) Dr A Conway Appointed 28 May 2018; resigned 13 January 2025 Dr R E Cureton Appointed 10 October 2018 Ms S Dalton Appointed 23 October 2023; Mr G House Appointed 23 October 2023; Ms G A Miles Appointed 10 October 2018 Mr C Nagle Appointed 28 November 2018; resigned 20 August 2024 Mr H N Nguyen Appointed 2 December 2024 Ms J C Beker Appointed 2 December 2024

Chief Executive Officer

Mark Linington, Appointed 1[st] April 2020

Charity registered number

1178552

Registered office

35 Tottenham Lane London N8 9BD

Independent auditors

Goldwins Limited 75 Maygrove Road West Hampstead London NW6 2EG

Bankers

Barclays Bank Plc, Edgware, Middlesex HA

1

CDS UK (Clinic for Dissociative Studies) TRUSTEES’ ANNUAL REPORT FOR THE PERIOD FROM 1st APRIL 2024 to 31st MARCH 2025

The Trustees are pleased to present their seventh Trustees’ Report together with the financial statements of the charitable organisation for the period form 1[st] April 2024 to 31[st] March 2025.

This report has been coordinated by our CEO, Mark Linington, Head of Finance, Eyal Efrat and our current Board of Trustees (October 2025).

Mission, Vision and Values

To improve the lives of people affected by dissociative disorders through psychotherapeutic treatment, research, training and support

To provide and develop high quality treatments for dissociative disorders and expand opportunities to access them.

Respect, Choice, Compassion, Openness and Working Together

CDS UK (Clinic for Dissociative Studies) is a clinic which provides therapeutic packages to patients experiencing dissociative disorders, in particular dissociative identity disorder (D.I.D.). These disorders arise most often develop as a response to early and prolonged extreme trauma and abuse, often including sexual abuse. Sometimes the context reported by patients is of group organised and ritualised abuse.

CDS UK works mainly as a recognised independent provider to the UK National Health Service. CDS UK provides assessments of potential dissociative disorders, diagnoses, outpatient treatment, clinical supervision and training. At CDS UK we also run and participate in research and education initiatives, contributing to a greater understanding of dissociative disorders.

Activities

CDS UK conducts a number of activities including:

2

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

2024 – 2025 Highlights

Public benefit

The Trustees have had regard to the guidance issued by the Charity Commission concerning public benefit. They are satisfied that the information given in this report, particularly regarding the activities undertaken when read in conjunction with the objects of the charity, demonstrates that the requirements to identify public benefit have been met.

Plans for 2025/2026

The two year Business Plan was launched on 16[th] November 2024 at the CDS UK Annual Meeting. Since that date and throughout 2025 CDS UK has continued to utilise the business planning process. The Business Plan is due for review in November 2025, when progress will be evaluated and priorities for projects will be agreed for 2026. The Business Plan outlines the following priority objectives for 2024/2026. We will provide a report

3

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

on the progress towards our objectives in our next Annual Report 2025/2026.

1. Clinical

2. Business and Administration

4

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

3. Finance

4. Charitable

5

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

5. Board

Work towards the achievement of these objectives is reviewed at an appropriate frequency, at Board meetings, through individual line management and appraisal meetings and at the whole organisational meetings which are held twice yearly.

Structure, governance, and management

Governing document

CDS UK (Clinic for Dissociative Studies) is a Charitable Incorporated Organisation (CIO) (charity number 1178552) registered with the Charity Commission in May 2018. Prior to this, the organisation operated as a limited company.

Organisation

CDS UK currently has the following organisational structure:

We will continue to review and develop our organisational structure throughout 2025-2026 in line with the changing needs of CDS UK.

6

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

Appointment of Trustees

Trustees have been appointed with a view to their relevant experience, interests and areas of expertise. Currently, our Board of Trustees brings specialist knowledge and experience in regard to research, clinical experience including a psychological perspective, patient experience, knowledge and experience of the NHS and voluntary sector in regard to work with people with dissociative disorders and more broadly, charity and other organisational knowledge and experience, including financial and human resources management. We plan to maintain and develop further the knowledge and expertise of our Board of Trustees.

Trustee induction and training

Training for Trustees is by practice, encouragement to attend appropriate courses and informal mentorship from other Trustees. New Trustees are given an induction pack comprising a copy of the Charity Commission ‘Welcome Pack for New Trustees’, a copy of the Clinic’s Constitution, the minutes of at least three Trustee meetings and a Charity Trustee form stating that they acknowledge and accept their responsibilities as Trustees, which they must sign and return. They also attend briefing sessions.

Related parties and co-operation with other organisations

None of our Trustees receive remuneration or other benefit from their work as a Trustee for the charity without full Board approval. Only expenses incurred in the performance of Trustees’ duties can be reimbursed. Any connection between a Trustee or a member of staff of the charity must be disclosed in the same way as any other contractual relationship with a related party.

Financial review

The financial period from 1st April 2024 to 31st March 2025 is the accounting period covered by this report. A surplus was achieved of £200,928.

Investment policy

Currently, CDS UK did not hold any investments quoted on a Stock Exchange as all our surplus funds are held in cash. All surplus funds were held with one financial institution.

Reserves policy

The policy of the Trustees is to maintain a level of reserve that will provide a stable base from which to fund the charity’s future activities, including capital expenditure. The target set is £1,032,601 which represents 6 months expenditure that could be drawn upon if required by the Trustees for specific purposes as agreed by them. If cash is required to meet our requirements, this can be realised from investments, including property.

The free reserves currently exceed the target level; the trustees are mindful of the need to retain funds in reserve to fund both unforeseen costs and the ongoing maintenance costs of the charity’s premises. Given the anticipated level of work required in respect of the building over the coming years, the trustees consider the level of reserves held to be reasonable and appropriate.

During 2025 the Trustees will be reviewing our reserves policy and if appropriate accessing specialist financial advice to inform our future policy.

7

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

Risk management

The Trustees have a Risk Register which details:

The Risk Register is reviewed and updated by the CEO and the Trustees. This register sets out the major risks to which CDS UK is exposed and the systems which have been established to mitigate those risks.

Internal financial management risks are reduced through the implementation of internal controls in respect of the recording and the authorisation of all accounting transactions. Budgets are set for all types of expenditure; these are monitored by senior management and the Trustees.

Attention is also focused on mitigating non-financial risks arising from safeguarding, fire, health and safety, security and vulnerable adult safeguarding. This is overseen by the senior management team and the Trustees.

Statement of trustees’ responsibilities

The Trustees are responsible for preparing the Trustees’ Report and financial statements in accordance with applicable law and with the United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the income and expenditure of the charitable company for that period.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Each of the Trustees confirms that:

8

CDS UK (Clinic for Dissociative Studies) TRUSTEE’S ANNUAL REPORT FOR THE YEAR ENDED PERIOD FROM 1st April 2024 to 31st MARCH 2025

This confirmation is given and should be interpreted in accordance with the provisions of S418 of the Companies Act 2006.

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Dr R Cureton On behalf of the Board of Trustees

19 January 2026

9

INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)

Opinion

We have audited the financial statements of CDS UK (Clinic for Dissociative Studies) for the year ended 31 March 2025 which comprise the Statement of Financial Activities, the Balance Sheet, statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditorʼs responsibiliJes for the audit of the financial statements section of our report. We are independent of the Charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRCʼs Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Charity and environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.

10

INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)

We have nothing to report in respect of the following matters in relation to which the Charities Act 2011 requires us to report to you if, in our opinion:

Responsibilities of the trustees

As explained more fully in the trustees’ responsibilities statement, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the Charityʼs ability to conJnue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so.

Our responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditorʼs report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and noncompliance with laws and regulations, our procedures included the following:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

11

INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF CDS UK (CLINIC FOR DISSOCIATIVE STUDIES)

This report is made solely to the Charity’s trustees, as a body, in accordance with section 144 of the Charities Act 2011 and the regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the Charityʼs trustees those matters we are required to state to them in an auditorʼs report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity and the Charityʼs trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Goldwins

Goldwins Limited Statutory Auditor Chartered Accountants 75 Maygrove Road West Hampstead London NW6 2EG

29 January 2026

12

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Statement of financial activities

(incorporating an income and expenditure account)

For the year ended 31 March 2025

Note
Income from:
Donations and legacies
3
Charitable activities:
4
Therapy related activities
Investment income
5
Total income
Expenditure on:
Charitable activities:
6
Therapy related activities
Total expenditure
7
Transfers between funds
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
Net income
Unrestricted
Funds
£
85
2,232,638
33,407
2,266,130
2,061,574
2,061,574
204,556
-
204,556
2,388,716
2,593,272
Restricted
Funds
£
-
-
-
-
3,628
3,628
(3,628)
-
(3,628)
21,059
17,431
2025
Total
Funds
£
85
2,232,638
33,407
2,266,130
2,065,202
2,065,202
200,928
-
200,928
2,409,775
2,610,703
2024
Total
Funds
£
23
2,145,603
28,764
2,174,390
1,857,690
1,857,690
316,700
-
316,700
2,093,075
2,409,775

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. The attached notes form part of these financial statements.

13

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Balance sheet

As at 31 March 2025

Note
Fixed assets:
Intangible assets
9
10
Current assets:
11
Liabilities:
12
Liabilities:
13
15
Total unrestricted funds
Total funds
Unrestricted funds:
Debtors
Creditors: amounts falling due after more than
one year
Total assets less current liabilities
Tangible assets
Cash at bank and in hand
Creditors: amounts falling due within one year
Net current assets
Total net assets
Funds
General funds
Restricted funds
2025
£
418,431
1,680,771
2025
£
117,300
985,588
1,102,888
1,679,833
2,782,721
(172,018)
2,610,703
17,431
2,593,272
2,610,703
2024
£
466,262
1,499,691
2024
£
152,566
985,980
1,138,546
1,559,114
2,099,202
(419,369)
1,965,953
(406,839)
2,593,272 2,388,716
2,697,660
(287,885)
2,409,775
21,059
2,388,716
2,409,775

The financial statements were approved by the trustees on 19/01/2026 and signed on their behalf by:

Dr R Cureton - Trustee

Charitable Incorporated Organisation: 1178552

The attached notes form part of the financial statements.

14

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Statement of cash flows For the year ended 31 March 2025

Note
2025
£
Cash flows from operating activities:
Cash generated from operations
16
273,133
Interest paid
(9,593)
Cash provided by / (used in) operating activities
Cash flows from investing activities:
Interest/ rent/ dividends from investments
33,407
Sale/ (purchase) of fixed assets
-
Cash provided by / (used in) investing activities
Cash flows from financing activities:
Loan repayments
(115,867)
Cash provided by / (used in) investing activities
Change in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
17
Note
2025
£
Cash flows from operating activities:
Cash generated from operations
16
273,133
Interest paid
(9,593)
Cash provided by / (used in) operating activities
Cash flows from investing activities:
Interest/ rent/ dividends from investments
33,407
Sale/ (purchase) of fixed assets
-
Cash provided by / (used in) investing activities
Cash flows from financing activities:
Loan repayments
(115,867)
Cash provided by / (used in) investing activities
Change in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
17
2025
£
263,540
33,407
(115,867)
2024
£
139,290
(12,830)
2024
£
126,460
27,196
(119,630)
33,407
-
28,764
(1,568)
(115,867) (119,630)
181,080
1,499,691
34,026
1,465,665
1,680,771 1,499,691

15

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

1 Accounting policies

a) Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102 - effective 1 January 2019) - (Charities SORP FRS 102).

CDS UK (Clinic for Dissociative Studies) meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note.

b) Going concern

As at January 2026, the charity is addressing an ongoing legal dispute relating to non-clinical matters arising from activities undertaken by individuals formerly involved in the charity's governance. This requires professional advice and some of the charity's resources are expected to be dedicated to this matter going forwards. However, the Trustees do not currently expect this matter to be capable of causing a detrimental impact on the charity's ability to continue as a going concern.

The trustees consider that there are no material uncertainties about the charitable incorporated organisations's ability to continue as a going concern. The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.

Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred. Income received in advance for the provision of specified service is deferred until the criteria for income recognition are met.

d) Donations of gifts, services and facilities

Donated professional services and donated facilities are recognised as income when the charity has control over the item or received the service, any conditions associated with the donation have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), volunteer time is not recognised so refer to the trustees’ annual report for more information about their contribution.

On receipt, donated gifts, professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

e) Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

f) Fund accounting

Unrestricted funds are available to spend on activities that further any of the purposes of charity. Designated funds are unrestricted funds of the charity which the trustees have decided at their discretion to set aside to use for a specific purpose. Restricted funds are donations which the donor has specified are to be solely used for particular areas of the charity’s work or for specific projects being undertaken by the charity.

16

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

1 Accounting policies (continued)

g) Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure is classified under the following activity headings:

h) Allocation of support costs

i) Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised over its estimated useful life of ten years. The asset was initially purchased by Clinic For Dissociative Studies Limited (company no. 09093066) whose assets and liabilities were transferred to the charity on 18 October 2021.

j) Tangible fixed assets

The charity's freehold property comprises land and buildings including subsequent improvements to the property. Depreciation is not charged on the land element, which is instead subject to impairment review. No depreciation charge is made against the building and improvements as it is considered that the residual value of these is at least as great as the carrying value and not materially different to cost.

The charity operates a rolling repairs and maintenance programme to prolong the useful life of the property and to ensure that the above policy continues to be appropriate.

Other tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases Fixtures and fittings: 25% reducing balance Computer equipment: 25% reducing balance

k) Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

l) Taxation

The charity is exempt from tax on its charitable activities.

m) Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

n) Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

o) Financial instruments

p) Pensions

The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

17

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements

For the year ended 31 March 2025

2
Detailed comparatives for the statement of financial activities
2024
Funds
£
Income from:
Donations and legacies
23
Charitable activities:
Therapy related activities
2,145,603
Investments
28,764
Total income
2,174,390
Expenditure on:
Charitable activities:
1,853,748
Therapy related activities
Total expenditure
1,853,748
Net income / expenditure
320,642
Transfers between funds
(25,001)
Net movement in funds
295,641
Total funds brought forward
2,093,075
Total funds carried forward
2,388,716
3
Income from donations and legacies
Restricted
£
£
Donations and legacies
85
-
Other income
-
-
85
-
4
Income from charitable activities
Unrestricted
Restricted
£
£
Therapy related activities
2,232,638
-
2,232,638
-
5
Income from investments
Unrestricted
Restricted
£
£
Bank interest
33,407
-
33,407
-
Unrestricted
Unrestricted
2
Detailed comparatives for the statement of financial activities
2024
Funds
£
Income from:
Donations and legacies
23
Charitable activities:
Therapy related activities
2,145,603
Investments
28,764
Total income
2,174,390
Expenditure on:
Charitable activities:
1,853,748
Therapy related activities
Total expenditure
1,853,748
Net income / expenditure
320,642
Transfers between funds
(25,001)
Net movement in funds
295,641
Total funds brought forward
2,093,075
Total funds carried forward
2,388,716
3
Income from donations and legacies
Restricted
£
£
Donations and legacies
85
-
Other income
-
-
85
-
4
Income from charitable activities
Unrestricted
Restricted
£
£
Therapy related activities
2,232,638
-
2,232,638
-
5
Income from investments
Unrestricted
Restricted
£
£
Bank interest
33,407
-
33,407
-
Unrestricted
Unrestricted
2024
Funds
£
-
-
-
-
3,942
3,942
(3,942)
25,001
21,059
-
Restricted
2024
Total
Funds
£
23
-
2,145,603
28,764
2,174,390
1,857,690
1,857,690
316,700
-
316,700
2,093,075
2,388,716 21,059 2,409,775
Restricted
£
-
-
-
Restricted
£
-
-
Restricted
£
-
-
2025
Total
£
85
-
85
2025
Total
£
2,232,638
2,232,638
2025
Total
£
33,407
33,407
2024
Total
£
23
-
23
2024
Total
£
2,145,603
2,145,603
2024
Total
£
28,764
28,764

18

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements

For the year ended 31 March 2025

6 Analysis of expenditure

Wages
Social security
Pensions
Rent, rates & water
Insurance
Light and heat
Telephone
Office & admin costs
Marketing and advertising
Main therapy contractors
Other clinic activities
IT costs
Repairs, maintenance & cleaning
Travel & refreshments
Consultancy fees
Bank charges
Goodwill amortisation
Fixtures & fittings depreciation
Loan interest
Trustees` expenses
Legal, professional and accounting fees
Profit or Loss on Disposal of fixed assets
Total expenditure
Therapy related
activities
2025
Total
£
£
820,160
820,160
83,742
83,742
36,858
36,858
7,606
7,606
12,841
12,841
2,201
2,201
-
-
4,409
4,409
512
512
895,774
895,774
50,217
50,217
31,954
31,954
22,539
22,539
14,128
14,128
19,457
19,457
104
104
35,266
35,266
392
392
9,593
9,593
241
241
17,208
17,208
-
-
2,065,202
2,065,202
Charitable activities
2024
Total
£
703,114
67,629
31,045
5,899
9,317
1,601
7
4,226
5,805
837,611
33,139
22,258
37,310
7,819
24,118
104
35,267
300
12,830
810
17,481
-
Therapy related
activities
£
820,160
83,742
36,858
7,606
12,841
2,201
-
4,409
512
895,774
50,217
31,954
22,539
14,128
19,457
104
35,266
392
9,593
241
17,208
-
2,065,202
1,857,690

19

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

7 Net income / (expenditure) for the year

This is stated after charging / (crediting): 2025 2024
£ £
Depreciation 392 300
Auditor's remuneration:
Audit fees 4,000 4,000

8 Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel

Staff costs were as follows:
Salaries and wages
Social security costs
Employer’s contribution to defined contribution pension schemes
2025
£
820,160
83,742
36,858
940,760
2024
£
703,114
67,629
31,045
801,788

The following number of employees received employee benefits (excluding employer pension) during the year between:

£100,000 - £109,999
£80,000 - £89,999
£70,000 - £79,999
£60,000 - £69,999
2025
No.
1
2
1
1
2024
No.
-
2
1
2

The total employee benefits including pension contributions of the key management personnel, were £125,750 (2024: £150,516).

The charity trustees were not paid or received any other benefits from employment with the Charity in the year (2024: Nil). No charity trustee received payment for professional or other services supplied to the charity (2024: Nil).

Staff numbers

The average number of employees (head count based on number of staff employed) during the year was as follows:

Therapy related activities 2025
No.
14
14
2024
No.
17
17

20

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

9. Intangible fixed assets

Cost
At the start of the year
At the end of the year
Amortisation
At the start of the year
Charge for the year
At the end of the year
Net book value
At the end of the year
At the start of the year
All of the above assets are used for charitable purposes.
10
Tangible fixed assets
Cost
At the start of the year
Additions in the year
Disposals in the year
At the end of the year
Depreciation
At the start of the year
Charge for the year
Disposals in the year
At the end of the year
Net book value
At the end of the year
At the start of the year
All of the above assets are used for charitable purposes.
£
984,712
-
-
Freehold
property
£
1,568
-
-
1,568
300
392
-
692
876
1,268
Computer
equipment
Goodwill
£
352,667
352,667
200,101
35,266
235,367
117,300
152,566
Total
£
986,280
-
-
984,712 986,280
-
-
-
300
392
-
- 692
984,712 985,588
984,712 985,980

11 Debtors

Trade debtors
Prepayments and accrued income
Creditors: amounts falling due within one year
Bank loans and overdrafts
Trade creditors
Taxation and social security
Other creditors
2025
£
408,916
9,515
418,431
2025
£
55,385
83,003
220,784
60,197
419,369
2024
£
458,924
7,338
466,262
2024
£
55,385
92,393
205,631
53,430
406,839

12 Creditors: amounts falling due within one year

21

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

13 Creditors: amounts falling due after more than one year

Bank loans
Other creditors
14
Analysis of net assets between funds
Fixed assets
Net current assets
Non current liabilities
Net assets at 31 March 2025
14a Analysis of net assets between funds (prior
Fixed assets
Net current assets
Non current liabilities
Net assets at 31 March 2024
15
Movements in funds
Restricted funds:
The Paracelsus Trust Fund
Total restricted funds
Unrestricted funds:
General funds
Total unrestricted funds
Total funds
15a Movements in funds (prior period)
Restricted funds:
The Paracelsus Trust Fund
Total restricted funds
Unrestricted funds:
General funds
Total unrestricted funds
Total funds
period).
£
21,059
At the start of
the year
£
-
Income
General
unrestricted
£
1,102,888
1,662,402
(172,018)
2025
£
123,726
48,292
172,018
Restricted
£
-
17,431
-
17,431
Restricted
£
-
-
-
-
Transfers
£
-
-
-
-
2024
£
191,592
96,293
287,885
Total
funds
£
1,102,888
1,679,833
(172,018)
2,593,272 2,610,703
General
unrestricted
£
1,138,546
1,559,114
(287,885)
Total
funds
£
1,138,546
1,559,114
(287,885)
2,409,775 2,409,775
£
(3,628)
Expenditure
£
17,431
At the end of
the year
21,059 - (3,628) 17,431
2,388,716 2,266,130 (2,061,574) 2,593,272
2,388,716 2,266,130 (2,061,574) 2,593,272
2,409,775 2,266,130 (2,065,202) - 2,610,703
£
-
At the start of
the period
£
-
Income
£
(3,942)
Expenditure
Transfers
£
25,001
25,001
(25,001)
(25,001)
£
21,059
At the end of
the period
- - (3,942) 21,059
2,093,075 2,174,390 (1,853,748) 2,388,716
2,093,075 2,174,390 (1,853,748) 2,388,716
2,093,075 2,174,390 (1,857,690) - 2,409,775

22

CDS UK (CLINIC FOR DISSOCIATIVE STUDIES) Notes to the financial statements For the year ended 31 March 2025

16 Reconciliation of net income / (expenditure) to net cash flow from operating activities

Reconciliation of net income / (expenditure) to net cash flow from operating activities
Net income / (expenditure) for the reporting period
(as per the statement of financial activities)
Depreciation and amortisation
Interest received
Interest paid
(Increase)/ decrease in debtors
Increase/ (decrease) in creditors
Net cash provided by / (used in) operating activities
2025
£
200,928
35,658
(33,407)
9,593
47,831
12,530
273,133
2024
£
316,700
35,567
(28,764)
12,830
(203,872)
6,829
139,290

17 Analysis of cash and cash equivalents

Analysis of cash and cash equivalents
Cash at bank and in hand
Total cash and cash equivalents
£
1,499,691
At the start of
the year
Cash flows
£
181,080
£
-
-
Other changes
£
1,680,771
At the end of
the year
1,499,691 181,080 1,680,771

18 Legal status of the charity

The charity is a charitable incorporated organisation.

19 Related party transactions

During the year, the charity paid £200 to Mrs. Gill Wyatt for the services she provided. She is the mother-in-law of Mr. Mark Linington, the CEO of the charity. (2024: £800)

23